[PDF][PDF] Impact of PET/CT on planning of radiotherapy in head and neck cancer
H Minn, S Suilamo, J Seppälä - QJ Nucl Med Mol Imaging, 2010 - academia.edu
Radiation therapy (RT) has a prominent role in the treatment of locally advanced head and
neck cancer. Image and biologically guided intensity modulated RT are becoming …
neck cancer. Image and biologically guided intensity modulated RT are becoming …
[HTML][HTML] Современные подходы к лучевому лечению опухолей полости рта
ВА Титова, ГП Снигирева… - Сибирский …, 2016 - cyberleninka.ru
Рост частоты плоскоклеточного рака орофарингеальной области (ОФО) и
преобладание местнораспространенных форм опухоли у 60% с ранним …
преобладание местнораспространенных форм опухоли у 60% с ранним …
[HTML][HTML] Monoclonal antibodies against autocrine motility factor suppress gastric cancer
HS Jung, SI Lee, SH Kang, JS Wang… - Oncology …, 2017 - spandidos-publications.com
Autocrine motility factor (AMF), which is a secreted form of phosphoglucose isomerase, is
mainly secreted by various tumors and has cytokine‑like activity. AMF is known to stimulate …
mainly secreted by various tumors and has cytokine‑like activity. AMF is known to stimulate …
[PDF][PDF] Advances in EGFR-directed therapy in head and neck cancer
G Numico, N Silvestris… - Front Biosci (Schol Ed …, 2011 - article.imrpress.com
Initial research showed that EGFR targeting through known single agents, both monoclonal
antibodies and small-molecule tyrosine-kinase inhibitors, applied to patients with refractory …
antibodies and small-molecule tyrosine-kinase inhibitors, applied to patients with refractory …
Targeted therapies in solid tumours: pinpointing the tumour's Achilles heel
G Kornek, E Selzer - Current pharmaceutical design, 2009 - ingentaconnect.com
It is now exactly 100 years ago (1908) that Paul Ehrlich, who is regarded as the inventor of
the concept of targeted therapy, received the Nobel Prize for Medicine. His initial perception …
the concept of targeted therapy, received the Nobel Prize for Medicine. His initial perception …
[PDF][PDF] 西妥昔单抗联合化疗或放疗治疗晚期头颈鳞癌的疗效评价
李金忠， 郑家伟， 张志愿 - 上海口腔医学, 2008 - sjos.cn
表皮生长因子受体在头颈鳞状细胞癌广泛表达# 而且其表达水平与预后呈负相关% 因此作为B
种表皮生长因子受体抑制剂# Cetuximab 在治疗头颈鳞癌中的研究受到广泛关注 …
种表皮生长因子受体抑制剂# Cetuximab 在治疗头颈鳞癌中的研究受到广泛关注 …
头颈部鳞癌患者血清血管内皮生长因子和人表皮生长因子受体-2 水平的检测及临床意义
甘世新， 姚景春， 乔飞飞 - 山西医药杂志, 2014 - cqvip.com
目的探讨头颈部鳞癌患者血清血管内皮生长因子(VEGF) 和人表皮生长因子受体-2 (HER2)
表达情况与临床病理参数的关系以及二者之间的相互关系. 方法收集60 例头颈部鳞癌患者血清 …
表达情况与临床病理参数的关系以及二者之间的相互关系. 方法收集60 例头颈部鳞癌患者血清 …
Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)
É Lartigau - Bulletin du cancer, 2007 - jle.com
John Libbey Eurotext - Bulletin du Cancer - Angiogenesis and radiotherapy (vessels,
anaemia, oxygen and radiosensitivity) John Libbey Eurotext Home Bookstore Search for …
anaemia, oxygen and radiosensitivity) John Libbey Eurotext Home Bookstore Search for …
表皮生长因子受体靶向治疗在头颈部鳞癌中的研究现状
冯守昊， 嵇庆海， 王玉龙 - 中国癌症杂志, 2012 - cqvip.com
头颈部鳞癌(headnecksquamouseellcarcinoma, SCCHN) 外科治疗和放化疗技术虽不断发展,
但疗效并未获得满意的改善. 作为一种新的抗肿瘤治疗方式, 表皮生长因子受体 …
但疗效并未获得满意的改善. 作为一种新的抗肿瘤治疗方式, 表皮生长因子受体 …
[HTML][HTML] Aspects on Head and neck Cancer with special reference to Salivary Gland Tumours and Single Nucleotide Polymorphism
L Cederblad - 2017 - diva-portal.org
For dose planning PET/CT (Positron emissions tomography/computed tomography) with
tracer gave more precise information in comparison dose planning with CT. More primary …
tracer gave more precise information in comparison dose planning with CT. More primary …